Author: Brady Ruffin

Second-year Meharry Student Wins Third Place for CEnR Breast Cancer Study

Cristen Flewellen, a second-year Meharry medical student, was awarded Third Place in the Community Research category at the 67th Annual Meharry Student Research Day for her work with the Breast cancer Risk Assessment- achieVing Equity (BRAVE) study funded through the Meharry Vanderbilt Tennessee State Cancer Partnership (MVTCP). The BRAVE study PIs are  Lucy Spalluto, MD

MVTCP Leadership attended PACHE 2023 meeting in Rockville, MD

The meeting theme: “Building on a Solid Foundation to Strategically Strengthen and Enhance PACHE.” The gathering brought together PACHE (U54/P20) investigators, Program Managers, and NCI/CRCHD staff to discuss progress made by the program as well as topics that are important for the continued growth of PACHE. Photo of MVTCP Leadership: C. Whitted(MVA), L. Stewart(MMC), A.

Publication: Physicians/Patients Identify Differences and Impact on Delayed Cancer Care in JAMA Oncology

A new study authored by Vishal R. Patel, BS, Dr. Alex B. Haynes, MD, MPH (Dell Medical School, The University of Texas at Austin), Dr. Karen Winkfield, M.D., PhD (Meharry-Vanderbilt Alliance, Vanderbilt University Medical Center, Nashville, TN), Dr. Arjun Gupta, MD, Dr. Anne H. Blaes, MD, MS (Masonic Cancer Center, University of Minnesota, Minneapolis), Dr.

VICC Medical Scientist Training Program Hosts Kunle Odunsi, MD, PhD for Flexner Discovery Lecture

Dr. Kunle Odunsi, MD, PhD,a new member of the Meharry Vanderbilt Tennessee State Cancer Partnership (MVTCP) Program Steering Committee, will present at the upcoming Flexner Discovery Lecture, hosted by theVanderbilt-Ingram Cancer Center (VICC) Medical Scientist Training Program. Dr. Odunsi is the Director of the Comprehensive Cancer Center, Dean for Oncology, and AbbVie Distinguished Service Professor

22nd Annual MVTCP Symposium

On Saturday, February 25, the Meharry-Vanderbilt-Tennessee State University Cancer Partnership (MVTCP) hosted the 22nd Annual MVTCP Symposium entitled “Cancer Health Disparities: From Bench to Bedside to Community.”  Faculty members from Meharry Medical College, Vanderbilt University Medical Center, Tennessee State University, and members of the Nashville community joined together at Meharry’s West Basic Sciences Building to

Spring 2022 Genomics and Personalized Medicine Seminar

Please join for the final presentation of the spring 2022 Genomics and Personalized Medicine seminar next week. Jeffrey N. Weitzel, MD Vice President of Medical Affairs, Hereditary Cancer, Natera Professor, Latin American School of Oncology “Addressing global implementation of genomic cancer risk assessment – Lessons learned in Latin America” May 3, 2022 2-3PM Please click